|
(V980) |
The impact of ischemic burden on cardiac outcomes in patients who undergo dobutamine stress cardiac magnetic resonance. Is one ‘culprit’ segment enough to predict adverse outcomes? |
| |
|
S. Giusca, S. Kelle, E. Nagel, S. Buß, V. Puntmann, E. Wellnhofer, E. Fleck, H. A. Katus, G. Korosoglou (Heidelberg, Berlin; London, UK) |
|
|
Diskussion |
|
(V981) |
MRI-derived changes of cardiac function and scar size within 4 months and long-term clinical outcome in patients with acute myocardial infarction |
| |
|
J. Steiner, D. Leistner, I. Ziegler, S. de Waha, I. Eitel, T. Dill, J. Klotsche, J. Wöhrle, H. Thiele, A. M. Zeiher (Frankfurt am Main, Leipzig, Düsseldorf, Dresden, Ulm) |
|
|
Diskussion |
|
(V982) |
Prognostic Significance of Worst Lead Residual ST-segment Elevation in Patients with Acute Reperfused ST-elevation Myocardial Infarction – Insights from Cardiovascular Magnetic Resonance |
| |
|
K.-P. Rommel, M. Mende, S. Desch, M. Gutberlet, G. C. Schuler, H. Thiele, I. Eitel (Leipzig) |
|
|
Diskussion |
|
(V983) |
Myocardium at risk im Nicht-ST-Hebungsinfarkt – Korrelation zwischen Magnetresonanztomographie und dem Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease Score (APPROACH) |
| |
|
D. Buckert, N. Dyckmanns, V. Rasche, W. Rottbauer, P. Bernhardt (Ulm) |
|
|
Diskussion |
|
(V984) |
The presence of myocardial scar carries additional prognostic information in patients with diabetes who undergo late gadolinium enhancement magnetic resonance imaging |
| |
|
S. Giusca, S. Kelle, E. Nagel, S. Buß, V. Puntmann, E. Fleck, H. A. Katus, G. Korosoglou (Heidelberg, Berlin; London, UK) |
|
|
Diskussion |
|
(V985) |
Does the localization of ischemia in patients who undergo dobutamine stress cardiac magnetic resonance imaging influence outcome? |
| |
|
S. Giusca, S. Kelle, E. Nagel, S. Buß, V. Puntmann, E. Wellnhofer, E. Fleck, H. A. Katus, G. Korosoglou (Heidelberg, Berlin; London, UK) |
|
|
Diskussion |